Miao Qu

Dr. Miao Qu

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2015 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
GFGermaine Fung
Germaine Fung
YDYi Deng
Yi Deng
QZQing Zhao
Qing Zhao
ZLZhi Li
Zhi Li
MQMiao Qu
Miao Qu
RCRaymond C. K. Chan
Raymond C. K. Chan
The clinical presentation of common symptoms during depressive episodes in bipolar disorder (BD) and major depressive disorder (MDD) poses challenges for accurate diagnosis. Disorder-specific neuroanatomical features may aid the development of reliable discrimination between these two clinical conditions. For our sample of 16 BD patients, 19 MDD patients and 29 healthy volunteers, we adopted vertex-wise cortical based brain imaging techniques to examine cortical thickness and surface area, two components of cortical volume with distinct genetic determinants. Based on specific characteristics of neuroanatomical features, we then used support vector machine (SVM) algorithm to discriminate between patients with BD and MDD. Compared to MDD patients, BD patients showed significantly larger cortical surface area in the left bankssts, precuneus, precentral, inferior parietal, superior parietal and the right middle temporal gyri. In addition, larger volumes of subcortical regions were found in BD patients. In SVM discriminative analyses, the overall accuracy was 74.3 %, with a sensitivity of 62.5 % and a specificity of 84.2 % (p = 0.028). Compared to controls, larger surface area in the temporo-parietal regions were observed in BD patients, and thinner cortices in fronto-temporal regions were observed in MDD patients, especially in the medial orbito-frontal area. These findings have demonstrated distinct spatially distributed variations in cortical thickness and surface area in patients with BD and MDD, suggesting potentially varying etiological and neuropathological processes in these two conditions. The employment of multimodal classification on disorder-specific biological features has shed light to the development of potential classification tools that could aid diagnostic decisions.

20 April 2016 in Mass Spectrometry Reviews
Verified
Journal Article
Closed access
PDF file
MQMiao Qu
Miao Qu
BABo An
Bo An
SSShichen Shen
Shichen Shen
MZMing Zhang
Ming Zhang
XSXiaomeng Shen
Xiaomeng Shen
Jun  QuJun Qu
Jun Qu

28 December 2020 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YCYujia Cao
Yujia Cao
LHLiyuan Huang
Liyuan Huang
TSTong Si
Tong Si
NWNing Qun Wang
Ning Qun Wang
MQMiao Qu
Miao Qu
Xiangyang ZhangXiangyang Zhang
Xiangyang Zhang

1 June 2013 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
QZQing Zhao
Qing Zhao
YMYan-Tao Ma
Yan-Tao Ma
SLSimon SY Lui
Simon SY Lui
WLWen-Hua Liu
Wen-Hua Liu
TXTing Xu
Ting Xu
RCRaymond C.K. Chan
Raymond C.K. Chan

5 August 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
SSShichen Shen
Shichen Shen
BABo An
Bo An
XWXue Wang
Xue Wang
SHShannon P. Hilchey
Shannon P. Hilchey
JLJun Li
Jun Li
Jun  QuJun Qu
Jun Qu

24 August 2023 in Brain Pathology
Verified
Journal Article
Open access
YNYuting Nie
Yuting Nie
CCChangbiao Chu
Changbiao Chu
QQQi Qin
Qi Qin
HSHuixin Shen
Huixin Shen
LWLulu Wen
Lulu Wen
MQMiao Qu
Miao Qu
Lipid metabolism and oxidative stress are key mechanisms in Alzheimer's disease (AD). The link between plasma lipid metabolites and oxidative stress in AD patients is poorly understood. This study was to identify markers that distinguish AD and amnestic mild cognitive impairment (aMCI) from NC, and to reveal potential links between lipid metabolites and oxidative stress. We performed non‐targeted lipid metabolism analysis of plasma from patients with AD, aMCI, and NC using LC–MS/MS. The plasma malondialdehyde (MDA), glutathione peroxidase (GSH‐Px), and superoxide dismutase (SOD) levels were assessed. We found significant differences in lipid metabolism between patients with AD and aMCI compared to those in NC. AD severity is associated with lipid metabolites, especially TG (18:0_16:0_18:0) + NH4, TG (18:0_16:0_16:0) + NH4, LPC(16:1e)‐CH3, and PE (20:0_20:4)‐H. SPH (d16:0) + H, SPH (d18:1) + H, and SPH (d18:0) + H were high‐performance markers to distinguish AD and aMCI from NC. The AUC of three SPHs combined to predict AD was 0.990, with specificity and sensitivity as 0.949 and 1, respectively; the AUC of three SPHs combined to predict aMCI was 0.934, with specificity and sensitivity as 0.900, 0.981, respectively. Plasma MDA concentrations were higher in the AD group than in the NC group (p = 0.003), whereas plasma SOD levels were lower in the AD (p < 0.001) and aMCI (p = 0.045) groups than in NC, and GSH‐Px activity were higher in the AD group than in the aMCI group (p = 0.007). In addition, lipid metabolites and oxidative stress are widely associated. In conclusion, this study distinguished serum lipid metabolism in AD, aMCI, and NC subjects, highlighting that the three SPHs can distinguish AD and aMCI from NC. Additionally, AD patients showed elevated oxidative stress, and there are complex interactions between lipid metabolites and oxidative stress.